August 05, 2020
Framingham, MA — SCIEX a global leader in life science analytical technologies, and 908 Devices, a pioneer of purpose-built analytical devices for chemical and biomolecular analysis, announce the general availability of the ZipChip® platform on SCIEX mass spectrometers (MS). With this release, SCIEX expands its suite of MS front end separation solutions, providing additional flexibility to MS researchers for both large and small molecules.
The ZipChip platform by 908 Devices is an electrophoretic separation device based on microfluidic technology that directly integrates electrospray ionization with mass spectrometry. Compatible MS systems include the SCIEX Triple Quad™, QTRAP® and high-end TripleTOF® systems.
“For decades, scientists developing biotherapeutics have relied on the data provided by SCIEX mass spectrometry systems to help bring safe and effective drugs to market,” says Mani Krishnan, Vice President and General Manager of Biopharma at SCIEX.
For biotherapeutic developers, it is important to obtain comprehensive information and critical quality attributes. The ZipChip platform paired with a SCIEX mass spectrometer allows quick, routine characterization of biotherapeutics on an intact and near-native level.
“The ability to integrate the ZipChip platform with SCIEX Triple Quad and TripleTOF platforms enables customers to increase drug development efficiency through additional rapid, high-resolution separation techniques. It demonstrates our continued commitment to provide relevant solutions to help biotherapeutic developers accelerate their protein characterization efforts,” continues Krishnan.
“We are excited to see the continued expansion of the ZipChip platform with a pioneer in the CE-MS space such as SCIEX. Customers now have broader access to this enabling technology through ordering from SCIEX,” says Dr. Trent Basarsky, VP and GM of Life Sciences, 908 Devices. “Delivering fast separations with high quality data while requiring only minimal method development has resonated strongly with our customers. Extending these capabilities to the SCIEX community will allow them to solve more problems and maximize their MS efficiency.”
SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research.
With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit sciex.com
SCIEX social: @SCIEXnews, LinkedIn, and Facebook.
We make point-of-need-devices ranging from rugged, handheld chemical detection tools to compact, tiny footprint analyzers and fast separation devices. These uncomplicated purpose-built devices provide users with the power to redefine their workflows by getting actionable answers at the point of need. Our devices are being used for critical applications across the globe in the life sciences and field forensic markets. 908 Devices is headquartered in the heart of Boston, where we research, design and manufacture innovative products based on high-pressure mass spectrometryTM (HPMS) and microfluidic separation technology. For more information, visit www.908devices.com.
Contact Information
Lulu VanZandt
Program Manager, Brand, Public Relations and Social Media, SCIEX
lulu.vanzandt@sciex.com
+1 (508) 383-7163
M: +1 (508) 782-9484
AB Sciex is operating as SCIEX.
© 2018 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used under license.
For research use only. Not for use in diagnostic procedures.